Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Elevation Oncology, Inc. (ELEV) position

Not anymore: Ken Griffin fully exited ELEV in Q3 2025. The position peaked at an amount we cannot price in Q4 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
355K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

ELEV price vs Griffin's position

Dates
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2025 Exited −355K −100.0% 0 Nov 14, 2025
Q2 2025 New +355K 355K Aug 14, 2025
Q4 2024 New +266K 266K Feb 14, 2025
Q2 2024 Reduced −1.5M −97.4% 40K Aug 14, 2024
Q1 2024 Added +978K +165.4% 1.6M May 15, 2024
Q4 2023 Reduced −249K −29.6% 591K Feb 14, 2024
Q3 2023 Added +2K +0.2% 840K Nov 14, 2023
Q2 2023 New +839K 839K Aug 14, 2023
Q4 2021 New +22K 22K Feb 14, 2022
Data through Q3 2025 · filed Nov 14, 2025
9 grouped rows from 9 quarters

More Griffin positions

Common questions

Does Ken Griffin own ELEV?

Not currently. Ken Griffin fully exited ELEV in Q3 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy ELEV?

Ken Griffin first disclosed a ELEV position in Q4 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell ELEV?

Yes. Ken Griffin reduced and then fully exited ELEV by Q3 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ELEV does Ken Griffin own?

None as of the latest filing: Ken Griffin has exited ELEV. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for ELEV?

Ken Griffin began building the ELEV position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.